Deep Dive: Deep Dive Into Huntington's Disease

Dr. Daniel Claassen, a Huntington's disease specialist and the head of Vanderbilt’s HD Center of Excellence, joins Deep Dive to discuss the recent news that Roche and Wave Life Sciences were discontinuing the development of their respective HD treatments, May what promise still remains in the pipeline, and how crucial it is for the HD community to maintain hope in light of these 2 failures.